Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions
Bone Metastases
Interventions
RADIATION

Conventional Radiotherapy

Conventional radiotherapy will be used (8 Gy/ 1 fraction).

RADIATION

Biological image-guided radiotherapy with conventional dose.

Biological image-guided radiotherapy on the positron emitting tomography (PET) positive lesion with conventional dose (8Gy/ 1 fraction) will be used.

RADIATION

Biological image-guided SBRT with dose-escalation.

Biological image-guided stereotactic body radiotherapy (SBRT) with dose-escalation on the PET positive lesion will be used.

Trial Locations (2)

9000

Ghent University Hospital, Ghent

Unknown

University Hospital Antwerp, Antwerp

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT01429493 - Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases | Biotech Hunter | Biotech Hunter